DR. ROUMEN BALABANOV, M.D.
Neurology at Saint Clair St, Chicago, IL
License number
Illinois 036105349
Category
Neurology
Type
Neurology
Address
Address
675 N Saint Clair St, Chicago, IL 60611
Phone
(312) 695-7950
(312) 695-2184 (Fax)
(312) 695-2184 (Fax)
Personal information
See more information about ROUMEN BALABANOV at radaris.comName
Address
Phone
5647 Maryland Ave, Chicago, IL 60637
5740 Kenwood Ave, Chicago, IL 60637
10121 Wehrman Pl, Schiller Park, IL 60176
5740 Maryland Ave, Chicago, IL 60637
Professional information
Dr. Roumen Balabanov, Chicago IL - MD (Doctor of Medicine)
Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
1725 W Harrison St, Chicago 60612
(312) 942-8011 (Phone)
(312) 942-8011 (Phone)
Certifications:
Neurology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
1725 W Harrison St, Chicago 60612
Rush University Medical Center
1653 West Congress Pkwy, Chicago 60612
Rush University Medical Center
1653 West Congress Pkwy, Chicago 60612
Education:
Residency Hospital
University Of Chicago Hosps
University Of Chicago Hosps
Roumen D Balabanov, Chicago IL
Specialties:
Neurologist
Address:
1725 W Harrison St, Chicago, IL 60612
Education:
Doctor of Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Assistant Professor Of Neurology At Rush University Medical Center
Position:
Assistant Professor of Neurology at Rush University Medical Center
Location:
Greater Chicago Area
Industry:
Hospital & Health Care
Work:
Rush University Medical Center
-
Assistant Professor of Neurology
Dna Methylation Based Test For Monitoring Efficacy Of Treatment
US Patent:
2010014, Jun 10, 2010
Filed:
Dec 4, 2009
Appl. No.:
12/631622
Inventors:
Victor Levenson - Chicago IL, US
Anatoliy Melnikov - Glenview IL, US
Roumen Balabanov - Chicago IL, US
Dusan Stefoski - Chicago IL, US
Anatoliy Melnikov - Glenview IL, US
Roumen Balabanov - Chicago IL, US
Dusan Stefoski - Chicago IL, US
Assignee:
RUSH UNIVERSITY MEDICAL CENTER - Chicago IL
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A DNA methylation-based test for efficiency of treatments is based on a plurality of genes. The test is suitable for monitoring treatment of subjects with neurological diseases, e.g., multiple sclerosis (MS); with cancer, e.g., breast and ovarian cancer, and with other diseases for which methylation of biomarkers differs in the diseased compared to the non-diseased state.
Differential Labeling Of Cells
US Patent:
2008010, May 8, 2008
Filed:
Aug 10, 2007
Appl. No.:
11/837437
Inventors:
Brian Popko - Chicago IL, US
Roumen Balabanov - Chicago IL, US
Trent Watkins - Palo Alto CA, US
Roumen Balabanov - Chicago IL, US
Trent Watkins - Palo Alto CA, US
International Classification:
A01K 67/00, C12Q 1/68, C12N 15/00, C12N 5/06
US Classification:
800003000, 435006000, 435320100, 435325000, 800013000, 800009000
Abstract:
The invention relates to the generation of an animal model that exhibits neural cell-specific expression of a marker gene that correlates to remyelination or myelin repair. The compositions and methods embodied in the present invention are particularly useful for drug screening and/or treatment of demyelination disorders, particularly in identifying compounds that promote or inhibit remyelination.